A project identifying potential risk factors leading to diabetic ketoacidosis in patients with type 1 diabetes treated with an insulin pump

Diabetic ketoacidosis (DKA) is a life threatening condition in people with type 1 diabetes (T1D).[1][1] With 10–30% of people in developed countries on insulin pump therapy for managing T1D, DKA in such patients can result in fatal or near-fatal consequences.[2][2]–[4][3] Despite its severity,